pI: 6.7107 |
Length (AA): 577 |
MW (Da): 67278 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127471)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G25350 | putative tRNA-glutamine ligase |
Babesia bovis | BBOV_III006400 | glutaminyl-tRNA synthetase family protein |
Brugia malayi | Bm1_12965 | glutaminyl-tRNA synthetase |
Candida albicans | CaO19_7064 | hypothetical protein |
Candida albicans | CaO19.7064 | glutaminyl-tRNA synthetase |
Caenorhabditis elegans | CELE_Y41E3.4 | Protein QARS-1, isoform D |
Cryptosporidium hominis | Chro.10244 | glutaminyl-tRNA synthetase |
Cryptosporidium parvum | cgd1_2130 | glutaminyl-tRNA synthetase, of predicted bacterial origin |
Dictyostelium discoideum | DDB_G0289481 | glutamine-tRNA ligase |
Drosophila melanogaster | Dmel_CG10506 | Glutaminyl-tRNA synthetase |
Escherichia coli | b0680 | glutamyl-tRNA synthetase |
Echinococcus granulosus | EgrG_000248300 | glutaminyl tRNA synthetase |
Entamoeba histolytica | EHI_062700 | glutaminyl-tRNA synthetase, putative |
Echinococcus multilocularis | EmuJ_000248300 | glutaminyl tRNA synthetase |
Giardia lamblia | GL50803_9348 | Glutaminyl-tRNA synthetase |
Homo sapiens | ENSG00000172053 | glutaminyl-tRNA synthetase |
Leishmania braziliensis | LbrM.15.1430 | glutaminyl-tRNA synthetase, putative |
Leishmania donovani | LdBPK_151490.1 | glutaminyl-tRNA synthetase, putative |
Leishmania infantum | LinJ.15.1490 | glutaminyl-tRNA synthetase, putative |
Leishmania major | LmjF.15.1440 | glutaminyl-tRNA synthetase, putative |
Leishmania mexicana | LmxM.15.1440 | glutaminyl-tRNA synthetase, putative |
Loa Loa (eye worm) | LOAG_11368 | glutaminyl-tRNA synthetase |
Loa Loa (eye worm) | LOAG_05553 | hypothetical protein |
Mus musculus | ENSMUSG00000032604 | glutaminyl-tRNA synthetase |
Neospora caninum | NCLIV_062230 | Glutaminyl-tRNA synthetase (EC 6.1.1.18), related |
Neospora caninum | NCLIV_062220 | Glutaminyl-tRNA synthetase (EC 6.1.1.18), related |
Oryza sativa | 4337996 | Os05g0182800 |
Oryza sativa | 4325653 | Os01g0185200 |
Plasmodium berghei | PBANKA_1346600 | glutamine--tRNA ligase, putative |
Plasmodium falciparum | PF3D7_1331700 | glutamine--tRNA ligase, putative |
Plasmodium knowlesi | PKNH_1268800 | glutamine--tRNA ligase, putative |
Plasmodium vivax | PVX_082520 | glutamine--tRNA ligase, putative |
Plasmodium yoelii | PY02178 | glutaminyl-tRNA synthetase, putative |
Saccharomyces cerevisiae | YOR168W | glutamine--tRNA ligase |
Schistosoma japonicum | Sjp_0203800 | ko:K01886 glutaminyl-tRNA synthetase [EC6.1.1.18], putative |
Schistosoma mansoni | Smp_148050 | glutaminyl-tRNA synthetase (glutamine--tRNA ligase) (glnrs) |
Schmidtea mediterranea | mk4.071411.00 | |
Schmidtea mediterranea | mk4.002657.02 | Probable glutamineALQ-tRNA ligase |
Schmidtea mediterranea | mk4.002223.03 | Probable glutamineALQ-tRNA ligase |
Schmidtea mediterranea | mk4.001346.07 | Probable glutamineALQ-tRNA ligase |
Schmidtea mediterranea | mk4.002657.03 | Probable glutamineALQ-tRNA ligase |
Trypanosoma brucei gambiense | Tbg972.9.2750 | glutaminyl-tRNA synthetase, putative |
Trypanosoma brucei | Tb927.9.5210 | glutaminyl-tRNA synthetase, putative |
Trypanosoma congolense | TcIL3000_9_1710 | glutaminyl-tRNA synthetase, putative |
Trypanosoma cruzi | TcCLB.508277.160 | glutaminyl-tRNA synthetase, putative |
Toxoplasma gondii | TGME49_217460 | glutaminyl-tRNA synthetase (GlnRS) |
Theileria parva | TP02_0322 | glutaminyl-tRNA synthetase, putative |
Trichomonas vaginalis | TVAG_258380 | glutaminyl-tRNA synthetase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.160.3730 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.160.3730 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.160.3730 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.160.3730 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0680 | Escherichia coli | essential | goodall |
CELE_Y41E3.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y41E3.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y41E3.4 | Caenorhabditis elegans | slow growth | wormbase |
YOR168W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1346600 | Plasmodium berghei | Essential | plasmo |
TGME49_217460 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | glutaminyl-tRNA synthetase | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
Tb927.9.5210 | purified protein | BRENDA | A protein with this EC number or name or sequence has been purified from Trypanosoma brucei ( 1 ) |
1 literature reference was collected for this gene.